4 Results for "

Prazosin (Standard)

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Prazosin (Standard)" in MCE Product Catalog:

Cat. No.: HY-B0193R
CAS No.: 19216-56-9
Prazosin (Standard) is the analytical standard of Prazosin. This product is intended for research and analytical applications. 0
loading...
    loading...
Cat. No.: HY-B0193AR
CAS No.: 19237-84-4
Prazosin (hydrochloride) (Standard) is the analytical standard of Prazosin (hydrochloride). This product is intended for research and analytical applications. Prazosin hydrochloride is a well-tolerated, CNS-active α1-adrenergic receptor antagonist for the research of high blood pressure and alcohol use disorders . Prazosin hydrochloride potently inhibits Norepinephrine (NE)-stimulated 45Ca efflux with an IC50 of 0.15 nM [2].Prazosin hydrochloride inhibits organic cation transporters OCT-1 and OCT-3 with IC50s of 1.8, and 13 μM, respectively .
loading...
    loading...
Cat. No.: HY-106954R
CAS No.: 152735-23-4
Synonyms: Rec 15/2739 (Standard); Recordati 15/2739 (Standard); SB 216469 (Standard)
Upidosin (Standard) (Rec 15/2739 (Standard)) is the analytical standard of Upidosin (HY-106954). This product is intended for research and analytical applications. Upidosin (Rec 15/2739) is an α-1 adrenoceptor (α-1 AR) antagonist. Upidosin shows moderate selectivity for the α-1A AR subtype. Upidosin shows uroselectivity in urethra and prostate with a Kb value of 2-3 nM higher than in ear artery and aorta with a Kb value of 20-100 nM. Upidosin inhibits [3H]prazosin binding to cloned human α-1A adrenergic receptor. Upidosin can be used for the research of urethral obstruction .
loading...
    loading...
Cat. No.: HY-108347R
CAS No.: 142715-48-8
Research Areas:  

Metabolic Disease

CP-100356 hydrochloride (Standard) is the analytical standard of CP-100356 (hydrochloride) (HY-108347). This product is intended for research and analytical applications. CP-100356 hydrochloride is an orally active dual MDR1 (P-gp)/BCRP inhibitor, with an IC50s of 0.5 and 1.5 µM for inhibiting MDR1-mediated Calcein-AM transport and BCRP-mediated Prazosin transport, respectively. CP-100356 hydrochloride is also a weak inhibitor of OATP1B1 (IC50=∼66 µM). CP-100356 hydrochloride is devoid of inhibition against MRP2 and major human P450 enzymes (IC50>15 µM) .
loading...
    loading...